STOCK TITAN

Park Ha Biological Technology Co., Ltd. (BYAH) Stock Price, News & Analysis

BYAH NASDAQ

Ticker history: PHH became BYAH (Park Ha Biological Technology Co., Ltd.) on . Earlier news and filings retain their original names and dates. View PHH history.

Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
95 252 sessions, October 30, 2025 to October 30, 2026
Largest daily move
+150% close of June 8, 2026
1-year change
-98.5% closing prices, October 30, 2025 to October 30, 2026
1-month change
-4.3% closing prices, September 30, 2026 to October 30, 2026

Company Description

Park Ha Biological Technology Co., Ltd. (Nasdaq: BYAH) is a company whose business activities, according to available information, center on skincare and cosmetic products marketed under the Park Ha brand in China. The company is involved in developing its own private skincare label and distributing these products through direct sales and franchise-related promotion channels. Its brand positioning focuses on providing solutions for problematic skin, and its operating subsidiaries handle both product development and customer-facing services in physical locations.

Business focus and activities

Park Ha Biological Technology Co., Ltd. is engaged in the development of proprietary beauty and skincare products under the Park Ha name. Park Ha Biological Technology Co., Ltd.’s operating subsidiaries provide skincare and cosmetic products under this brand in China and are responsible for creating and refining the company’s own beauty formulations.

The company also conducts direct skincare product sales and participates in franchise alliances promotions. This indicates that, in addition to selling products directly, it works with franchise partners to promote its brand and offerings. Its physical stores provide complimentary after-sales beauty services, which are positioned as a way to support customers who use Park Ha products and to reinforce the brand’s focus on problematic skin.

Brand positioning

The Park Ha brand is described as focusing on solutions for problematic skin. Within this framework, the company emphasizes proprietary beauty products and after-sales beauty services offered in physical stores. These services are characterized as complimentary and are intended to support customers following their purchase of Park Ha skincare or cosmetic products.

Trading symbol and Nasdaq listing

Park Ha Biological Technology Co., Ltd. has announced that its ordinary shares trade on Nasdaq. The company stated that it would change its ticker symbol from PHH to BYAH, and that, effective on October 28, 2025, its ordinary shares would trade on Nasdaq under the new symbol BYAH. The company has indicated that its ordinary shares will continue to be listed on Nasdaq in connection with this symbol change and that the CUSIP will remain unchanged.

According to the company’s announcement, the purpose of the ticker symbol change is to prevent potential confusion with a previously delisted company that used the same symbol. The company also stated that it expects the change of ticker symbol to support the development of its long-term brand influence and brand value.

Corporate structure and operations

Available information notes that Park Ha Biological Technology Co., Ltd. operates through its operating subsidiaries, which develop proprietary beauty products and offer complimentary after-sales beauty services in physical stores. These subsidiaries are responsible for providing skincare and cosmetic products under the Park Ha brand in China.

The company’s activities, as described, combine product development, brand-focused marketing, and in-person services. Direct skincare product sales and franchise alliances promotions are mentioned as key channels through which the Park Ha brand is promoted and its products are brought to customers.

Investor considerations

From an investor information standpoint, Park Ha Biological Technology Co., Ltd. presents itself as a skincare and cosmetic products company with a specific focus on problematic skin and a brand-based strategy in China. Its Nasdaq listing under the symbol BYAH and the formal announcement of its ticker symbol change from PHH to BYAH are key structural details disclosed by the company.

Investors reviewing Park Ha Biological Technology Co., Ltd. can consider the company’s emphasis on proprietary product development, its use of physical stores to provide complimentary after-sales beauty services, and its reliance on both direct sales and franchise alliances promotions as described in available materials. The company has also publicly communicated that the ticker symbol change is intended to avoid confusion with a delisted company that previously used the same symbol and to support its brand-building efforts.

Stock Performance

$2.21
-3.91%
-0.09
Last updated: October 30, 2026 at 16:00
-98.5%
Performance 1 year

Park Ha Biological Technology Co., Ltd. (BYAH) closed at $2.21 on October 30, 2026. Over the past 12 months, the price has lost 98.5%.

See what a $1,000 investment in BYAH would be worth today

Average down calculator for BYAH

BYAH Metrics & Rankings

October 2026
-4.3%
View ranking
YTD
-96.5%
View ranking

Price returns through October 30, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

Park Ha Biological Technology Co., Ltd. has 9 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include partnership, AI, offering. View all BYAH news →

Financial Highlights

Park Ha Biological Technology Co., Ltd. generated $2.5M in revenue in FY2025, retaining a 94.4% gross margin, operating income reached -$24.1M, and net income was -$24.4M. Diluted earnings per share stood at -$41.38. The company generated $86K in operating cash flow. The current ratio was 2.92, measuring current assets divided by current liabilities.

$2.5M
Revenue (FY2025)
-$24.4M
Net Income (FY2025)
$86K
Operating Cash Flow

Upcoming Events

No upcoming events scheduled for BYAH.

Short Interest History

Last 12 Months

Short interest in Park Ha Biological Technology Co., Ltd. (BYAH) currently stands at 29.6 thousand shares, up 32.9% from the previous reporting period, representing 1.3% of the float. Since the latest stock split, short interest has decreased by 34.1%, measured from August 2026.

Days to Cover History

Last 12 Months

Days to cover for Park Ha Biological Technology Co., Ltd. (BYAH) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 2.3 days.

BYAH Company Profile & Sector Positioning

Park Ha Biological Technology Co., Ltd. (BYAH) operates in the Household & Personal Products industry within the broader Consumer Defensive sector and is listed on the NASDAQ.

Investors comparing BYAH often look at related companies in the same sector, including Grove Collaborative Holdings, Inc. (GROV), United-Guardian, Inc. (UG), Big Tree Cloud Holdings Limited (DSY), Solesence, Inc. (SLSN), and Tantech Holdings Ltd. (TANH). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BYAH's relative position within its industry.

Frequently Asked Questions

What is the current stock price of Park Ha Biological Technology Co., Ltd. (BYAH)?

The current stock price of Park Ha Biological Technology Co., Ltd. (BYAH) is $2.21 as of October 30, 2026.

What is the revenue of Park Ha Biological Technology Co., Ltd. (BYAH) stock?

The FY2025 revenue of Park Ha Biological Technology Co., Ltd. (BYAH) is $2.5M, from its most recent completed fiscal year.

What is the net income of Park Ha Biological Technology Co., Ltd. (BYAH)?

The FY2025 net income of Park Ha Biological Technology Co., Ltd. (BYAH) is -$24.4M, from its most recent completed fiscal year.

What is the earnings per share (EPS) of Park Ha Biological Technology Co., Ltd. (BYAH)?

The diluted earnings per share (EPS) of Park Ha Biological Technology Co., Ltd. (BYAH) is -$41.38 for FY2025, its most recent completed fiscal year. Learn more about EPS .

What is the operating cash flow of Park Ha Biological Technology Co., Ltd. (BYAH)?

The operating cash flow of Park Ha Biological Technology Co., Ltd. (BYAH) is $86K for FY2025, its most recent completed fiscal year. Learn about cash flow.

What is the gross margin of Park Ha Biological Technology Co., Ltd. (BYAH)?

The gross profit margin of Park Ha Biological Technology Co., Ltd. (BYAH) is 94.4% for FY2025, its most recent completed fiscal year. Learn about gross margins.

What is the current ratio of Park Ha Biological Technology Co., Ltd. (BYAH)?

The current ratio of Park Ha Biological Technology Co., Ltd. (BYAH), current assets divided by current liabilities, was 2.92 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

What is the gross profit of Park Ha Biological Technology Co., Ltd. (BYAH)?

The gross profit of Park Ha Biological Technology Co., Ltd. (BYAH) is $2.4M for FY2025, its most recent completed fiscal year.

What is the operating income of Park Ha Biological Technology Co., Ltd. (BYAH)?

The operating income of Park Ha Biological Technology Co., Ltd. (BYAH) is -$24.1M for FY2025, its most recent completed fiscal year. Learn about operating income.

What does Park Ha Biological Technology Co., Ltd. do?

Park Ha Biological Technology Co., Ltd. is involved in developing its private skincare label and providing skincare and cosmetic products under the Park Ha brand in China. Its activities include direct skincare product sales, franchise alliances promotions, and complimentary after-sales beauty services in physical stores.

What is the focus of the Park Ha brand?

The Park Ha brand focuses on providing solutions for problematic skin. According to available information, the company’s operating subsidiaries develop proprietary beauty products and offer after-sales beauty services that support customers using Park Ha skincare and cosmetic products.

Where does Park Ha Biological Technology Co., Ltd. offer its products?

Available information states that the operating subsidiaries of Park Ha Biological Technology Co., Ltd. provide skincare and cosmetic products under the Park Ha brand in China. These activities include product development, sales, and after-sales beauty services in physical stores.

How does Park Ha Biological Technology Co., Ltd. sell and promote its products?

Park Ha Biological Technology Co., Ltd. engages in direct skincare product sales and franchise alliances promotions. This means it sells products directly and also works with franchise partners to promote the Park Ha brand and its skincare and cosmetic offerings.

What kind of services are offered in Park Ha physical stores?

According to available information, the operating subsidiaries of Park Ha Biological Technology Co., Ltd. offer complimentary after-sales beauty services in their physical stores. These services are intended to support customers after they purchase Park Ha skincare and cosmetic products.

On which exchange does Park Ha Biological Technology Co., Ltd. trade and under what symbol?

Park Ha Biological Technology Co., Ltd. has announced that its ordinary shares are listed on Nasdaq. The company stated that it would change its ticker symbol from PHH to BYAH, and that its ordinary shares would trade on Nasdaq under the new symbol BYAH effective October 28, 2025.

Why did Park Ha Biological Technology Co., Ltd. change its ticker symbol to BYAH?

The company announced that it would change its ticker symbol from PHH to BYAH to prevent potential confusion with a delisted company that previously used the same symbol. It also stated that the change is expected to have a positive impact on building its long-term brand influence and enhancing its brand value.

Does the ticker symbol change to BYAH affect existing shareholders?

According to the company’s announcement, no action is required by existing shareholders in connection with the ticker symbol change from PHH to BYAH. The company also indicated that its ordinary shares will continue to be listed on Nasdaq and that the CUSIP will remain unchanged.